Percutaneous valve-in-valve implantation using an inverted aortic valve is feasible for treating a dysfunctional tricuspid bioprosthesis in a pediatric patient, potentially postponing surgical replacement.
Supports feasibility of jugular valve-in-valve for pediatric tricuspid bioprosthesis dysfunction; leaves open durability and broader applicability.
We report a successful percutaneous revalvulation of a dysfunctional tricuspid bioprothesis in an 8-year-old child. Five years after implanting a 25-mm Carpentier-Edwards valve in the tricuspid position, the prosthesis showed significant dysfunction with clinical right heart failure. A 26-mm Edwards-Sapien XT inverted aortic valve was successfully implanted through a 19F sheath using a jugular approach. Such procedure can significantly postpone the need for surgical replacement of a biological valve.
No takes yet. Share an insight, caveat, or question.
Gewillig et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: